TIF illuminates the latest developments with investigational drugs and therapies for the treatment of thalassaemia and sickle cell disease, which are currently in various phases of clinical trials.
Many pharmaceutical companies are making remarkable progress in their research into candidate treatments for these diseases and 2022 is expected to be yet another eventful year for haemoglobin disorders!
Check out the Clinical Trial Updates section of our website and keep abreast of all the advances occurring right now. Simply click on the available buttons and read what interests you the most — or, even better, everything!
Visit our Clinical Trial Updates page HERE